Triton Market Research presents the Global Immunohistochemistry Market report, segmented on the basis of Products (Antibodies, equipment, reagents, kits), Application (diagnostic, drug testing), End-Users (hospital and diagnostic laboratories, research institutes, other end users) and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
The report discusses industry value chain analysis, Porter's 5 Force Analysis, drivers, restraints, vendor profiles, global market size, forecasts & analysis (2019-2027).
Triton Market Research expects the Global Immunohistochemistry market to witness a compound annual growth rate (CAGR) of 7.21% during the forecast period of 2019-2027. Immunohistochemistry (IHC) is a term that includes immunological, biological and anatomical techniques to locate an image component of tissue with the assistance of antibodies-antigen interaction. The market is mainly driven by the rising prevalence of cardiovascular diseases mainly including high blood pressure.
The North American region has captured a significant share of the global immunohistochemistry market. Triton Market Research forecasts that this region will continue to have the upper hand throughout the projected years (2019-2027) in terms of CAGR. Demand quality of healthcare backed up by high expenditure in healthcare is the driving reason for IHC market in region. The U.S. and Canada are the major countries expected to increase their total health and research expenditure. On the other hand, Europe and Asia-Pacific are the other two significant regions holding the market uptight.
The growing prevalence of chronic diseases has led to an increase in demand for hospitals and diagnostic centers as end-users of the market. This, in turn, leads to growing the immunohistochemistry reagents, antibodies, and diagnostic procedure equipment in hospitals and laboratories.
In its market analysis report, Triton Market Research has profiled prominent market players like Abbott Laboratories, Abcam Plc., Agilent Technologies, Inc., Biogenex, Bio-Rad Laboratories Inc., Bio SB, Cell Signaling Technology Inc., Danaher Corporation, Hoffmann-LA Roche AG, Histologix, Merck Millipore, Perkinelmer Inc., Siemens AG Healthcare, Thermo Fisher Scientific Inc.
The IHC market is fairly fragmented due to the presence of many international, regional, and local players; ranging from large to small vendors. Thus, several market bigwigs are adopting strategies like mergers, acquisitions, and collaboration to maintain their supremacy in the global market. For instance, Hoffmann-LA Roche acquired mySugr to form a leading platform for digital diabetes management. The company aims to capitalize on digitalization and will assist the company in expanding its leading position in diabetes management. Abcam Plc signed an exclusive license agreement with Roche. Abcam will obtain the exclusive rights to the product portfolio of Spring Bioscience Corporation (“Spring”) in the research use only (RUO) field of use, comprising a total of approximately 760 unique products.
The Global Wood Based Panel Market is estimated to witness growth with a CAGR of 6..
The Global Sport Utility Vehicle (SUV) Market is estimated to grow with a CAGR of ..
The global market for cosmetic bioactive ingredients is expected to advance at a C..